Ulrich is a leader in our Chemicals practice, and directs our work in Specialty Chemicals in Europe. Most of his projects reflect his expertise in strategy, growth, and innovation and R&D, as well as his knowledge of mergers and acquisitions and biotechnology. He is based in Frankfurt.
Notable examples of Ulrich’s recent work include the following:
- Building long-term strategies for several global specialty chemical companies, often with focus on growth in emerging technology fields
- Helping chemical companies screen potential M&A targets, conduct due diligence, and facilitate post-merger integration
- Supporting large-scale reorganizations that involve the introduction of new operating models and governance structures
- Creating a portfolio of growth options for an industrial biotech player
- Optimizing the manufacturing network of a mid-sized chemical company
Ulrich also played an instrumental role in developing InnomaticsTM, our proprietary tool for helping chemical companies assess their innovation performance using both quantitative and qualitative metrics.
Before joining McKinsey in 2004, Ulrich worked as a research scientist at the European Molecular Biology Laboratories in Heidelberg, Germany. While earning a master’s degree in biochemistry from the University of Regensburg, he spent a year as an exchange student at Washington University, St. Louis.
“Winning in India: The specialty-chemicals opportunity,” McKinsey on Chemicals, Spring 2012
“The growing demand for green,” McKinsey on Chemicals, Spring 2012
“The future of industrial biorefineries,”World Economic Forum Report, 2010
“Setting the right course in biobased bulk chemicals,” McKinsey on Chemicals, Autumn 2008
“Finding the business opportunities in climate change,” McKinsey on Chemicals, Autumn 2008
“Is innovation helping or hurting your bottom line,” McKinsey on Chemicals, Autumn 2008
European Molecular Biology Laboratories
University of Heidelberg
PhD in biochemistry
University of Regensburg
MS in biochemistry